CTIS2024-514456-32-00进行中（未招募）1 期
A single-dose, randomized, two-period, two-sequence, crossover comparative bioavailability study on formulations containing ramipril, amlodipine and indapamide in combination product versus Triatec® 10 mg capsules (Sanofi - Produtos Farmacêuticos, Lda., Portugal), containing ramipril, Norvasc® 10 mg, tablets (Upjohn EESV, the Netherlands), containing amlodipine and Natrilix® 2.5 mg film-coated tablets (Les Laboratoires Servier, France), containing indapamide co-administered together as reference in healthy male and female volunteers under fasting conditions.
Zaklady Farmaceutyczne Polpharma S.A.0 个研究点目标入组 72 人开始时间: 2024年7月4日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 72
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
撤回
1 期
Comparative bioavailability assessment between 1 x 60 mg R-192 tablet and 1 x 60 mg R-107 tablet administered orally in healthy participants under fasting conditions.DepressionMental Health - DepressionMental Health - AnxietyAnxietyACTRN12622000446763Zenith Technology Corporation Limited14
撤回
1 期
Comparative bioavailability assessment between 2 x 10 mg R-178 tablets and 2 x 10 mg 2-amino-1,7-dihydro-6H-purine-6-thione tablets administered orally in healthy participants under fasting conditions.2-amino-1,7-dihydro-6H-purine-6-thione is indicated for the maintenance treatment of inflammatory bowel disease (Crohn's disease or ulcerative colitis).Oral and Gastrointestinal - Crohn's diseaseOral and Gastrointestinal - Inflammatory bowel diseaseACTRN12622000579796Zenith Technology Corporation Limited14
撤回
1 期
Comparative bioavailability assessment between 4 x 60 mg R107 tablets administered orally and 0.5mg/kg ketamine IV infusion over 40 minutes in healthy male and female participants under fasting conditions.Mental Health - DepressionMental Health - AnxietyDepressionAnxietyACTRN12618001135202Zenith Technology Corporation Limited12
撤回
1 期
Comparative bioavailability assessment between R107 tablet and 60 mg ketamine IV solution administered orally in healthy male and female participants under fasting conditions.AnxietyMental Health - DepressionMental Health - AnxietyDepressionACTRN12618001133224Zenith Technology Corporation Limited12
已完成
1 期
A phase I biosimilar study to compare the pharmacokinetics, Pharmacodynamics, safety and tolerability of BP14 (Pegfilgrastim) with EU-approved Neulasta® in healthy male adult volunteers following a subcutaneous (SC- under the skin) injection.Chemotherapy-induced-neutropeniaCancer - Any cancerBlood - Haematological diseasesACTRN12620000657921CURATEQ BIOLOGICS PRIVATE LIMITED124